Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Needle-localized open breast biopsy used to diagnose breast lesions
January 19th, 2006
Needle-localized open breast biopsy (NLOBB) with stereotactic guidance could be used to diagnose breast lesions. Researchers in Austria conducted a study "to retrospectively determine the lesion miss rate and false-negative rate of NLOBB with stereotactic guidance in a large study population. The ethical review board approved the study; the need for informed consent was waived. A total of 1115 stereotactic NLOBBs performed in 1068 women aged 22-90 years (mean age, 54 years) were tracked to determine outcomes." "In cases of malignancy, NLOBB was considered to be diagnostically successful. The mammographic outcomes in all patients with benign results...
Source: Women's Health Weekly (2006-01-19)
|
